FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387208045> ?p ?o ?g. }

• W4387208045 endingPage "S159" @default.
• W4387208045 startingPage "S159" @default.
• W4387208045 abstract "Isocitrate dehydrogenase 1 (IDH1) mutations confer gain-of-function activity by converting α-ketoglutarate (α-KG) to the oncometabolite D-2-hydroxyglutarate (D-2HG). IDH mutant tumors have fewer tumor-infiltrating CD8+ T cells and reduced PD-L1 expression compared with their wild type (WT) counterparts. In addition, 2-HG can directly inhibit the killing and proliferative functions of CD8+ T lymphocytes, and suggesting that 2-HG promotes an immunosuppressive TME. Several studies have shown that 2-HG can inhibit homologous recombination (HR) and weaken the DNA damage response (DDR), making them more sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors and radiotherapy (RT). At the same time, RT and PARP inhibition (PARPi) have been considered to be a new direction to stimulate antitumor immunity. Therefore, our study intends to use RT + PARPi to reverse the immunosuppressive microenvironment caused by IDH1 mutations, thereby promoting the therapeutic effect of immune checkpoint inhibitors.We compared the immune responses of clinical tissue samples and TCGA data from either IDH1mut or IDH1WT low-grade gliomas. We then established IDH1mut-overexpressing MC38 and GL261 cell lines to determine the antitumor effect of RT + PARPi. Apoptosis and immunogenic death markers were detected by flow cytometry, western blot (WB) and ELISA in these cell lines. Tumor growth and mouse survival curves were observed in both an MC38 subcutaneous and GL261 orthotopic tumor model. Changes in the composition of the immune microenvironment were assessed using flow cytometry. The mechanisms underpinning these compositional shifts were then further interrogated using various techniques, including WB, immunofluorescence, qRT-PCR, CRISPR/Cas9, and CD8+ T cell migration experiments.We observed that CD8+ T cell infiltration and expression of the chemokines CXCL10 and CCL5 of CD8+ T cells in IDH1mut tumors were significantly downregulated by immunohistochemistry and TCGA analysis. Gene enrichment analysis using the TCGA database found that IDH1 mutations downregulated interferon (IFN)-related signaling pathways. RT + PARPi induces more DNA damage and actives the CGAS-STING pathway compared with monotherapy, leading to more expression of IFN-β, CXCL10 and CCL5 at mRNA and protein level. In the MC38 subcutaneous tumor model, we found that RT + PARPi increased the infiltration of CD8+ T cells while enhancing the killing function of CD8+ T cells. We observed these same effects in the GL261 orthoma model, as well as increased proliferation function of CD8+ T cells. In addition, RT + PARPi increased the expression of PD-L1 and enhanced the therapeutic effect of immune checkpoint inhibitors.RT + PARPi reshapes the IDH1mut tumor immune suppression microenvironment, thereby potentiating the antitumor effect and efficiency of immune checkpoint inhibitor." @default.
• W4387208045 created "2023-09-30" @default.
• W4387208045 creator A5053269101 @default.
• W4387208045 creator A5060739065 @default.
• W4387208045 creator A5074518162 @default.
• W4387208045 creator A5076501465 @default.
• W4387208045 creator A5079974007 @default.
• W4387208045 creator A5086494716 @default.
• W4387208045 date "2023-10-01" @default.
• W4387208045 modified "2023-10-17" @default.
• W4387208045 title "PARP Inhibitor Plus Radiotherapy Reshapes IDH1 Mutation Tumor Immune Suppression Microenvironment Potentiating the Efficiency of Immune Checkpoint Inhibitor" @default.
• W4387208045 doi "https://doi.org/10.1016/j.ijrobp.2023.06.586" @default.
• W4387208045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784398" @default.
• W4387208045 hasPublicationYear "2023" @default.
• W4387208045 type Work @default.
• W4387208045 citedByCount "0" @default.
• W4387208045 crossrefType "journal-article" @default.
• W4387208045 hasAuthorship W4387208045A5053269101 @default.
• W4387208045 hasAuthorship W4387208045A5060739065 @default.
• W4387208045 hasAuthorship W4387208045A5074518162 @default.
• W4387208045 hasAuthorship W4387208045A5076501465 @default.
• W4387208045 hasAuthorship W4387208045A5079974007 @default.
• W4387208045 hasAuthorship W4387208045A5086494716 @default.
• W4387208045 hasConcept C153911025 @default.
• W4387208045 hasConcept C167672396 @default.
• W4387208045 hasConcept C182979987 @default.
• W4387208045 hasConcept C190283241 @default.
• W4387208045 hasConcept C203014093 @default.
• W4387208045 hasConcept C2776107976 @default.
• W4387208045 hasConcept C2777701055 @default.
• W4387208045 hasConcept C2779138821 @default.
• W4387208045 hasConcept C2780851360 @default.
• W4387208045 hasConcept C502942594 @default.
• W4387208045 hasConcept C54355233 @default.
• W4387208045 hasConcept C552990157 @default.
• W4387208045 hasConcept C553184892 @default.
• W4387208045 hasConcept C55493867 @default.
• W4387208045 hasConcept C71924100 @default.
• W4387208045 hasConcept C82381507 @default.
• W4387208045 hasConcept C86803240 @default.
• W4387208045 hasConcept C8891405 @default.
• W4387208045 hasConceptScore W4387208045C153911025 @default.
• W4387208045 hasConceptScore W4387208045C167672396 @default.
• W4387208045 hasConceptScore W4387208045C182979987 @default.
• W4387208045 hasConceptScore W4387208045C190283241 @default.
• W4387208045 hasConceptScore W4387208045C203014093 @default.
• W4387208045 hasConceptScore W4387208045C2776107976 @default.
• W4387208045 hasConceptScore W4387208045C2777701055 @default.
• W4387208045 hasConceptScore W4387208045C2779138821 @default.
• W4387208045 hasConceptScore W4387208045C2780851360 @default.
• W4387208045 hasConceptScore W4387208045C502942594 @default.
• W4387208045 hasConceptScore W4387208045C54355233 @default.
• W4387208045 hasConceptScore W4387208045C552990157 @default.
• W4387208045 hasConceptScore W4387208045C553184892 @default.
• W4387208045 hasConceptScore W4387208045C55493867 @default.
• W4387208045 hasConceptScore W4387208045C71924100 @default.
• W4387208045 hasConceptScore W4387208045C82381507 @default.
• W4387208045 hasConceptScore W4387208045C86803240 @default.
• W4387208045 hasConceptScore W4387208045C8891405 @default.
• W4387208045 hasIssue "2" @default.
• W4387208045 hasLocation W43872080451 @default.
• W4387208045 hasLocation W43872080452 @default.
• W4387208045 hasOpenAccess W4387208045 @default.
• W4387208045 hasPrimaryLocation W43872080451 @default.
• W4387208045 hasRelatedWork W1511425935 @default.
• W4387208045 hasRelatedWork W2013803620 @default.
• W4387208045 hasRelatedWork W2394354805 @default.
• W4387208045 hasRelatedWork W2563663251 @default.
• W4387208045 hasRelatedWork W3028822667 @default.
• W4387208045 hasRelatedWork W3197243161 @default.
• W4387208045 hasRelatedWork W3217412908 @default.
• W4387208045 hasRelatedWork W4281389645 @default.
• W4387208045 hasRelatedWork W4286629873 @default.
• W4387208045 hasRelatedWork W4387208045 @default.
• W4387208045 hasVolume "117" @default.
• W4387208045 isParatext "false" @default.
• W4387208045 isRetracted "false" @default.
• W4387208045 workType "article" @default.